LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0200 (40.00%)
May 22, 2026, 4:00 PM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $2.88 million as of May 22, 2026. Its market cap has decreased by -93.40% in one year.
Market Cap
2.88M
Enterprise Value
56.12M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 2.88M, a decrease of -98.73%. That is a compound annual growth rate of -59.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.88M | -91.67% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
| Aug 5, 2021 | 227.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioxytran | 3.91M |
| Adaptimmune Therapeutics | 3.18M |
| Eastgate Biotech | 3.17M |
| Iterum Therapeutics | 2.91M |
| ProtoKinetix | 2.74M |
| Eloxx Pharmaceuticals | 2.73M |
| Vaccinex | 2.68M |
| Hepion Pharmaceuticals | 2.56M |